Skinvisible, Inc.
SKVI
$0.23
-$0.07-23.33%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| SG&A Expenses | 45.25% | 9.15% | 26.46% | -3.74% | 15.93% |
| Depreciation & Amortization | 8.51% | 31.11% | 0.00% | 2.17% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 43.96% | 10.08% | 25.38% | -3.54% | 15.32% |
| Operating Income | -45.57% | -10.52% | -26.51% | 3.67% | -15.97% |
| Income Before Tax | 203.62% | 0.31% | -9.89% | 80.83% | 24.16% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 203.62% | 0.31% | -9.89% | 80.83% | 24.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 203.62% | 0.31% | -9.89% | 80.83% | 24.16% |
| EBIT | -45.57% | -10.52% | -26.51% | 3.67% | -15.97% |
| EBITDA | -46.97% | -9.58% | -27.69% | 3.89% | -16.64% |
| EPS Basic | 171.00% | 0.32% | -9.87% | 80.82% | 24.15% |
| Normalized Basic EPS | 13.64% | 0.25% | -10.00% | 80.82% | 24.14% |
| EPS Diluted | 169.06% | 0.32% | -15.13% | 80.82% | 25.67% |
| Normalized Diluted EPS | 13.64% | 0.25% | -7.63% | 80.82% | 24.14% |
| Average Basic Shares Outstanding | 45.95% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 45.95% | 0.00% | 2.20% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |